Q3 2020 Holdings
Filed 2020-11-16 | 22 holdings | $101.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Altimmune Inc(ALT) | COM | 02155H200 | $59.4M | 4,500,000 | 58.8% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $18.0M | 1,271,985 | 17.9% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $11.9M | 800,000 | 11.7% |
| ALX Oncology Holdings Inc(ALXO) | COM | 00166B105 | $11.3M | 300,000 | 11.2% |
| Trillium Therapeutics Inc | COM | 89620X506 | $102.4K | 7,204,577 | 0.1% |
| Constellation Pharmaceutical(CNST) | COM | 210373106 | $81.4K | 4,016,873 | 0.1% |
| Athira Pharma Inc | COM | 04746L104 | $28.1K | 1,521,623 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $26.8K | 3,877,895 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $25.9K | 672,306 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $25.1K | 668,440 | 0.0% |
| Humanigen Inc | COM | 444863104 | $24.8K | 2,332,516 | 0.0% |
| IMV Inc | COM | 44974L103 | $17.8K | 4,000,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $17.6K | 575,000 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $15.3K | 1,192,883 | 0.0% |
| Metacrine Inc | COM | 59101E103 | $11.7K | 1,143,673 | 0.0% |
| Unum Therapeutics Inc | COM | 903214104 | $10.2K | 4,355,273 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $9.2K | 625,710 | 0.0% |
| FS Development Corp | COM CL A | 303020101 | $5.6K | 500,000 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $5.2K | 500,000 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.6K | 107,982 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $467 | 51,653 | 0.0% |
| Medicenna Therapeutics Corp(MDNAF) | COM | 58490H107 | $383 | 92,453 | 0.0% |